Glanbia plc (FRA:GL9)
Germany · Delayed Price · Currency is EUR | Market Cap | 4.22B +78.3% |
| Revenue (ttm) | 3.36B +2.8% |
| Net Income | 156.06M +11.3% |
| EPS | 0.62 +16.0% |
| Shares Out | n/a |
| PE Ratio | 27.04 |
| Forward PE | 13.92 |
| Dividend | 0.43 (2.57%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | n/a |
| Average Volume | 53 |
| Open | 17.09 |
| Previous Close | 16.67 |
| Day's Range | 17.09 - 17.09 |
| 52-Week Range | 9.40 - 18.50 |
| Beta | n/a |
| RSI | 49.99 |
| Earnings Date | Aug 6, 2026 |
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services a... [Read more]
Financial Performance
In fiscal year 2025, Glanbia's revenue was $3.95 billion, an increase of 2.78% compared to the previous year's $3.84 billion. Earnings were $183.30 million, an increase of 11.29%.
Financial numbers in USD Financial StatementsNews
Glanbia to sell Slimfast US to Heartland Food Products group of US
Irish-based nutrition supplement maker Glanbia on Wednesday said it had agreed to sell its weight management brand SlimFast US to Heartland Food Products Group for an undisclosed sum.
Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More
Explore the booming Flax Protein Market: projected to soar from $38.54B in 2024 to $56.42B by 2029, driven by the rise in plant-based diets and demand for minimally processed foods. Explore the boomin...
Glanbia shares jump after 'better than feared' first quarter
Shares in nutrition supplement maker Glanbia jumped 10% on Wednesday after analysts pointed to a "better than feared" first quarter performance that allowed the Irish group to maintain its full year e...
Supplements producer Glanbia's shares dive on profit warning
Shares in nutrition supplement maker Glanbia slid by 15% on Wednesday after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise in the cost of whey, a...